One of the many doors money and power often open gives access to opioids where they would otherwise be withheld without strict oversight and management. Elvis Presley provides perhaps the most famous example of unmanaged access to drugs.
The question of whether and how results from personal genetic testing will motivate behavioral changes in consumers has only begun to receive the research attention it richly deserves.
Using the patient’s worldview to challenge his or her decision and establish a treatment plan—implying the view is shared by the physician when it is not—could be seen as manipulative and deceptive.
Social and behavioral data contained in electronic health records are essential for studying health disparities. Can researchers avoid bias when collecting, analyzing, and using such data?
AMA J Ethics. 2018;20(9):E873-880. doi:
10.1001/amajethics.2018.873.
Amy Scharf(理学硕士), Louis Voigt(医学博士), Santosha Vardhana(医学博士、哲学博士), Konstantina Matsoukas(图书情报硕士), Lisa M. Wall(哲学博士、注册护士、临床护理专家、高级肿瘤临床护理专家、已获认证的医疗保健伦理顾问), Maria Arevalo(注册护士、肿瘤专科护士), and Lisa C. Diamond(医学博士、公共卫生硕士)
AMA J Ethics. 2021;E97-108. doi:
10.1001/amajethics.2021.97.